2023 Annual Meeting | C47 - Clinical Pearls in Autoimmune Neurology: Real-world Cases

Date Sunday 04/23/23

Time 01:00 PM - 03:00 PM EST Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Sarosh R. Irani, MD, PhD, FRCP, FEAN

Topic(s) Autoimmune Neurology

Learning Objectives Participants should be able to recognize and become famliar with case-based descriptions of individual patients with some of the most treatable autoimmune neurologic conditions, across demyelination, encephalitis, and peripheral diseases; and recall, evaluate, and appraise both clinical and investigation features which lead to, and divert from, an accurate autoimmune diagnosis, including conditions with antibodies against AQP4, MOG, NMDAR, LGI1, CASPR2, Iglon5, Contactin-1, and NF-155.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Quality Improvement

Program Level Advanced

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:05 PM EST	Introduction	Session Aims and Outline Sarosh R. Irani, MD, PhD, FRCP, FEAN
01:05 PM - 01:35 PM EST	Speaker	Case-based Pearls and Errors in Diagnosing Demyelinating Conditions - MS, MOGAD, NMOSD and More Brian G. Weinshenker, MD, FAAN
01:35 PM - 01:45 PM EST	Q&A	Questions and Answers Brian G. Weinshenker, MD, FAAN
01:45 PM - 02:10 PM EST	Speaker	Case-based Pearls and Errors in Diagnosing Autoimmune Encephalitis and Related Syndromes Sarosh R. Irani, MD, PhD, FRCP, FEAN
02:10 PM - 02:20 PM EST	Q&A	Questions and Answers Sarosh R. Irani, MD, PhD, FRCP, FEAN
02:20 PM - 02:45 PM EST	Speaker	Case-based Pearls and Errors in Diagnosing Emerging Autoimmune Peripheral Nerve and Muscle Conditions Divyanshu Dubey, MD, FAAN
02:45 PM - 02:55 PM EST	Q&A	Questions and Answers Divyanshu Dubey, MD, FAAN
02:55 PM - 03:00 PM EST	Closing Remarks	Review of Aims and Closing Remarks Sarosh R. Irani, MD, PhD, FRCP, FEAN

Faculty Disclosures
Sarosh R. Irani, MD, PhD, FRCP, FEAN	Dr. Irani has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB, Cerebral therapeutics, Roche and Janssen. Dr. Irani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Irani has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain. Dr. Irani has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for LLPs. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care. Dr. Irani has received intellectual property interests from a discovery or technology relating to health care.
Brian G. Weinshenker, MD, FAAN	Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Weinshenker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CANbridge Pharmaceuticals. Dr. Weinshenker has received personal compensation in the range of $0-$499 for serving as a Consultant for CALIBR. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viela Bio. Dr. Weinshenker has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Group (Chugai, Genentech, Roche). Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharmaceuticals. The institution of Dr. Weinshenker has received research support from Guthy Jackson Charitable Foundation. Dr. Weinshenker has received intellectual property interests from a discovery or technology relating to health care. Dr. Weinshenker has received personal compensation in the range of $5,000-$9,999 for serving as a speaker at internal meeting and symposium with Horizon.
Divyanshu Dubey, MD, FAAN	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.